{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:36:57Z","timestamp":1784810217030,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jjcc.2024.06.001","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T17:00:48Z","timestamp":1718211648000},"page":"362-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hibiscus score: Developing and validating a predictive tool for intravenous immunoglobulin treatment resistance in Malaysian children with Kawasaki disease"],"prefix":"10.1016","volume":"84","author":[{"given":"Jenny Yee Chen","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"See Yee","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan Keat","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui Mun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamizatul","family":"Mohamed Zabidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Radzi","family":"Abu Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2024.06.001_bb0005","first-page":"189","article-title":"Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease","volume":"95","author":"Muta","year":"2006","journal-title":"Acta Paediatr Int J Paediatr"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0010","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0015","article-title":"The global epidemiology of Kawasaki disease: review and future perspectives","volume":"2017","author":"Lin","year":"2017","journal-title":"Glob Cardiol Sci Pract"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijcard.2016.03.017","article-title":"Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin","volume":"214","author":"Kibata","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0025","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial","volume":"379","author":"Kobayashi","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00431-011-1585-4","article-title":"A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease","volume":"171","author":"Zhu","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0035","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1542\/peds.2011-0148","article-title":"Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial","volume":"129","author":"Ogata","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12016-016-8581-4","article-title":"Effect and safety of TNF inhibitors in immunoglobulin-resistant Kawasaki disease: a meta-analysis","volume":"52","author":"Xue","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2008.06.011","article-title":"Infliximab treatment of intravenous immunoglobulin\u2013resistant Kawasaki disease","volume":"153","author":"Burns","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0050","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1067\/mpd.2000.104815","article-title":"Prediction of non-responsiveness to intravenous high-dose \u03b3-globulin therapy in patients with Kawasaki disease at onset","volume":"137","author":"Fukunishi","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","article-title":"Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease","volume":"149","author":"Egami","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","article-title":"Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment","volume":"166","author":"Sano","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2007.12.021","article-title":"Resistance to intravenous immunoglobulin in children with Kawasaki disease","volume":"153","author":"Tremoulet","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0070","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jfma.2015.03.012","article-title":"Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease","volume":"115","author":"Lin","year":"2015","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2010.10.031","article-title":"Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance","volume":"158","author":"Sleeper","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0080","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/archdischild-2014-307397","article-title":"Predicting IVIG resistance in UK Kawasaki disease","volume":"100","author":"Davies","year":"2015","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jpeds.2016.12.018","article-title":"Efficacy of four scoring systems in predicting intravenous immunoglobulin resistance in children with Kawasaki disease in a children\u2019s hospital in Beijing, North China","volume":"184","author":"Song","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0090","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00431-018-3297-5","article-title":"Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort","volume":"178","author":"Fabi","year":"2019","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0095","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0100","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0105","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1442-200X.1991.tb02612.x","article-title":"Intravenous \u03b3-globulin treatment in Kawasaki disease","volume":"33","author":"Harada","year":"1991","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2726686","article-title":"Predictors for intravenous immunoglobulin resistance in patients with Kawasaki disease","volume":"2022","author":"Li","year":"2022","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0115","first-page":"32","article-title":"Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease","volume":"87","author":"Koyanagi","year":"1998","journal-title":"Acta Paediatr Int J Paediatr"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0120","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/archdischild-2017-314512","article-title":"Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing","volume":"104","author":"Yang","year":"2019","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1442-200x.2005.02049.x","article-title":"Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease","volume":"47","author":"Takahashi","year":"2005","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/15513818509026899","article-title":"Hepatomegaly and splenomegaly in Kawasaki disease","volume":"4","author":"Ohshio","year":"1985","journal-title":"Pediatr Pathol"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/adc.2010.184101","article-title":"Assessment of intravenous immunoglobulin non-responders in Kawasaki disease","volume":"96","author":"Hwang","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0140","first-page":"29","article-title":"Prediction of intravenous immunoglobulin nonresponse Kawasaki disease in Korea","volume":"21","author":"Choi","year":"2014","journal-title":"J Pediatr Infect Dis"},{"key":"10.1016\/j.jjcc.2024.06.001_bb0145","first-page":"187","article-title":"Determination of the relationship between Kobayashi, Sano, and Egami criteria and prevalence of intravenous immunoglobulin resistance and coronary artery aneurysm in Iranian children with Kawasaki disease","volume":"12","author":"Shashaani","year":"2020","journal-title":"Open Access Rheumatol Res Rev"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508724001023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508724001023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T02:13:02Z","timestamp":1764555182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508724001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0914508724001023"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2024.06.001","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hibiscus score: Developing and validating a predictive tool for intravenous immunoglobulin treatment resistance in Malaysian children with Kawasaki disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2024.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}